MedPath

Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical Patients

Not Applicable
Completed
Conditions
MRSA Infection
Interventions
Other: Rapid molecular MRSA test
Behavioral: Hand hygiene promotion
Registration Number
NCT00685867
Lead Sponsor
University Hospital, Geneva
Brief Summary

The study is a two-arm controlled multi-centre trial of two strategies to reduce nosocomial MRSA transmission and infection among surgical patients. Enrolment and primary analyses will be performed at the hospital level. A total of ten adult surgical departments with at least 3 surgical subspecialties each will participate in the study. Sites of the study are located in 9 countries (UK, France, Spain, Germany, Switzerland, Italy, Serbia, Greece and Israel).

The primary objective is to determine the effect of an early MRSA detection \& decolonization \& isolation strategy compared to an enhanced standard control strategy on healthcare-associated MRSA isolation rates among surgical patients at risk of MRSA carriage, who are hospitalized for at least 24 hours.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126750
Inclusion Criteria
  • Surgical patients with LOS>24h
Exclusion Criteria
  • Surgical patients with LOS<24h

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Rapid molecular MRSA testRapid detection
2Hand hygiene promotionEnhanced infection control
Primary Outcome Measures
NameTimeMethod
Nosocomial MRSA isolation rate (expressed as the monthly rate of MRSA in clinical isolates divided by the number of susceptible patients per hundred)Monthly
Secondary Outcome Measures
NameTimeMethod
Nosocomial MRSA infection rate (= number of nosocomial MRSA infections per 100 admissions)Monthly

Trial Locations

Locations (1)

Geneva University Hospitals

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath